IP Library Granted Patent US 7,651,700
Granted Patent B2
US 7,651,700 · App. 10/332,978 · Granted Jan 26, 2010

Topical diclofenac patch

Assignees: Tokuhon Corporation; SSP Co., Ltd.; Dojin Iyaku-Kako Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,651,700
App. No.
10/332,978
Granted
Jan 26, 2010
Kind
B2
Abstract

The invention provides an analgesic anti-inflammatory patch of a hydrophobic type for topical application containing, in a Pressure Sensitive Adhesive (PSA), diclofenac sodium, pyrrolidone or a derivative thereof, a polyhydric alcohol fatty acid ester, and an organic acid. The patch exerts the following effects: (1) diclofenac sodium is effectively and continuously released from a Pressure Sensitive Adhesive (PSA) and percutaneously absorbed, thereby attaining sustained, excellent pharmaceutical and pharmacological effects; (2) the patch per se has high tackiness and safety; and (3) diclofenac sodium remains stable in the Pressure Sensitive Adhesive (PSA).

Claims (20)

1. An analgesic anti-inflammatory Pressure Sensitive Adhesive (PSA) patch fox topical application, comprising a soft support and a PSA layer on the soft support, wherein the PSA layer comprises

1 wt. % of diclofenac sodium,

2 to 4 wt. % of N-methyl-2-pyrrolidone,

2 wt. % of propylene glycol monocaprylate,

0.4 wt % of citric acid,

28.5 to 38 wt % of a styrene-isoprene-styrene block copolymer,

2 to 4 wt % polyisobutylene,

12 to 25 wt % of an ester gum,

30 to 40 wt % of liquid paraffin, and

no added water.

2. The patch of claim 1 , wherein the PSA layer further comprises l-menthol.

3. The patch of claim 1 , wherein the PSA layer contains 1 to 3 wt. % of the l-menthol.

4. The patch of claim 1 , wherein the PSA layer contains no l-menthol.

5. The patch of claim 1 , further comprising an anti-ageing agent.

6. The patch of claim 1 , wherein the soft support does not permit permeation of the PSA layer through the back of the support.

7. The patch of claim 1 , wherein the soft support is selected from the group consisting of woven fabrics, non-woven fabrics, plastic films, and films of a foamed blend of acrylic polymer or polystyrene-polybutadiene and polyisoprene.

8. The parch of claim 1 , wherein the soft support is a plastic film selected from the group consisting of polyolefin film, polyvinyl alcohol film, vinyl chloride film, urethane alloy film, urethane-vinyl chloride copolymer film, and ethylene-vinyl acetate film.

9. The patch of claim 8 , wherein the film is selected from the group consisting of plastic films, and films of a foamed blend of acrylic polymer or polystyrene-polybutadiene and polyisoprene.

10. The patch of claim 1 , wherein the soft support has a thickness of about 1,000 μm or less.

11. The patch of claim 1 , wherein the soft support has a thickness of 30-700 μm.

Assignments (4)
CHANGE OF ADDRESS Recorded Oct 5, 2018
From: SSP CO., LTD.
To: SSP CO., LTD.
Reel/Frame 047197/0129 →
SECURITY AGREEMENT Recorded Feb 2, 2010
From: CERIMON PHARMACEUTICALS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 023882/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2005
From: TOKUHON CORPORATION; SSP CO., LTD.
To: DOJIN IYAKU-KAKO CO., LTD. (33%)
Reel/Frame 016454/0924 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2003
From: SASAKI, YASUHIKO; MATSUMURA, YUKIHIRO; YAMAZAKI, MASARU; ARAI, HIROSHI; KAWABATA, SHOGO; SAITO, MASAAKI; OKUYAMA, HIROHISA; SUZUKI, MAKOTO
To: TOKUHON CORPORATION; SSP CO., LTD.
Reel/Frame 013920/0573 →
Priority Claims (1)
JP 2001-154008 · May 23, 2001 · national
Continuity (1)
Related Publication 20030175331A1 · Sep 18, 2003